These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 386753)
1. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 7. New horizons in beta-adrenoceptor blockade therapy: labetalol. Frishman W; Halprin S Am Heart J; 1979 Nov; 98(5):660-5. PubMed ID: 386753 [No Abstract] [Full Text] [Related]
2. Labetalol: a review of its pharmacology and therapeutic use in hypertension. Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1978 Apr; 15(4):251-70. PubMed ID: 25757 [TBL] [Abstract][Full Text] [Related]
3. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects. MacCarthy EP; Bloomfield SS Pharmacotherapy; 1983; 3(4):193-219. PubMed ID: 6310529 [TBL] [Abstract][Full Text] [Related]
4. Pharmacology of combined alpha-beta-blockade. I. Louis WJ; McNeil JJ; Drummer OH Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889 [TBL] [Abstract][Full Text] [Related]
5. The pharmacology of labetalol, an alpha- and beta-adrenoceptor blocking agent. Blakeley AG; Summers RJ Gen Pharmacol; 1978; 9(6):399-402. PubMed ID: 32121 [No Abstract] [Full Text] [Related]
6. Pharmacology of labetalol in experimental animals. Baum T; Sybertz EJ Am J Med; 1983 Oct; 75(4A):15-23. PubMed ID: 6314811 [TBL] [Abstract][Full Text] [Related]
7. A review of the haemodynamic effects of labetalol in man. Cohn JN; Mehta J; Francis GS Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):19S-26S. PubMed ID: 7093099 [TBL] [Abstract][Full Text] [Related]
13. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug. Brittain RT; Levy GP Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948 [TBL] [Abstract][Full Text] [Related]
14. Influences of labetalol a combined alpha- and beta-adrenergic blocking agent on the dysrhythmias induced by coronary occlusion and reperfusion. Pogwizd SM; Sharma AD; Corr PB Cardiovasc Res; 1982 Jul; 16(7):398-407. PubMed ID: 7127354 [No Abstract] [Full Text] [Related]
15. Comparison of labetalol with other anti-hypertensive drugs. Prichard BN; Richards DA Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):41S-47S. PubMed ID: 6124265 [TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of intravenous labetalol in essential hypertension. Dunn FG; Oigman W; Messerli FH; Dreslinski GR; Reisin E; Frohlich ED Clin Pharmacol Ther; 1983 Feb; 33(2):139-43. PubMed ID: 6822026 [TBL] [Abstract][Full Text] [Related]
17. Alpha-adrenoceptor blockade by labetalol during long-term dosing. Semplicini A; Pessina AC; Rossi GP; Hlede M; Morandin F Clin Pharmacol Ther; 1983 Mar; 33(3):278-82. PubMed ID: 6130864 [TBL] [Abstract][Full Text] [Related]
18. Combined alpha- and beta-receptor inhibition in the treatment of hypertension. Prichard BN Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891 [TBL] [Abstract][Full Text] [Related]
19. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise. Koch G Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950 [TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects. Mehta J; Cohn JN Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]